secwatch / observer
8-K filed November 19, 2021, 6:59 PM ET ticker ALKS CIK 0001520262
leadership confidence high sentiment neutral materiality 0.25

Alkermes appoints Dr. Cato T. Laurencin to Board under Sarissa Capital agreement

Alkermes plc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Cato T. Laurencin

Director
ALKS · Alkermes plc.
Effective
2021-11-18
Filed
November 19, 2021, 6:59 PM ET
On November 18, 2021, the Board of Directors (the “Board”) of Alkermes plc (the “Company”) increased the size of the Board to twelve (12) directors and elected Dr. Cato T. Laurencin to the Board, effective immediately, as a Class II member with a term expiring at the Company’s 2022 annual general meeting of shareholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Cato T. Laurencin was elected as Director at Alkermes plc..

Action
elected
Role
Director
Exact text from the filing
On November 18, 2021, the Board of Directors (the “Board”) of Alkermes plc (the “Company”) increased the size of the Board to twelve (12) directors and elected Dr. Cato T. Laurencin to the Board, effective immediately, as a Class II member with a term expiring at the Company’s 2022 annual general meeting of shareholders.
View on SEC.gov

Alkermes plc. filing history →

Source: SEC EDGAR
accession 0001564590-21-057694
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.